TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
4521 Stock 12 Month Forecast
There Are No Analyst Ratings for JP:4521 In The Last 3 Months.
Highest Price Target―
Average Price Target―
Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
4521 Financial Forecast
4521 Earnings Forecast
Next quarter’s earnings estimate for 4521 is ¥24.79 with a range of ¥24.79 to ¥24.79. The previous quarter’s EPS was ¥19.03. 4521 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year 4521 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 4521 is ¥24.79 with a range of ¥24.79 to ¥24.79. The previous quarter’s EPS was ¥19.03. 4521 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year 4521 has Performed in-line its overall industry.
4521 Sales Forecast
Next quarter’s sales forecast for 4521 is ¥19.37B with a range of ¥19.37B to ¥19.37B. The previous quarter’s sales results were ¥20.49B. 4521 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year 4521 has Performed in-line its overall industry.
Next quarter’s sales forecast for 4521 is ¥19.37B with a range of ¥19.37B to ¥19.37B. The previous quarter’s sales results were ¥20.49B. 4521 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year 4521 has Performed in-line its overall industry.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mark Yokoyama
UBS
Not Ranked
UBS
¥4,200
Hold
13.15%
Upside
Initiated
12/12/25
Kaken Pharmaceutical Co (KKPCF) Gets a Hold from UBS
trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +1.40% per trade.
Copying Jea Lee's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -0.18% per trade.
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -9.32% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
4521 Analyst Recommendation Trends
Rating
May 25
Jul 25
Aug 25
Sep 25
Dec 25
Strong Buy
3
3
5
6
5
Buy
2
2
0
0
0
Hold
0
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
5
6
6
In the current month, 4521 has received 5Buy Ratings, 1Hold Ratings, and 0Sell Ratings. 4521 average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
4521 Stock Forecast FAQ
What is JP:4521’s average 12-month price target, according to analysts?
Currently, no data Available
What is JP:4521’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for JP:4521, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Kaken Pharmaceutical Co a Buy, Sell or Hold?
Currently, no data Available
What is Kaken Pharmaceutical Co’s share price target?
Currently, no data Available
What do analysts say about Kaken Pharmaceutical Co?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Kaken Pharmaceutical Co?
To buy shares of JP:4521, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.